Plume provides access to telehealth consultations for patients seeking gender-affirming hormone therapy. Recently, the startup began partnering with employers to offer its services as a benefit.
Truepill, the startup behind direct-to-consumer health brands like Hims and Nurx, plans to expand into lab testing. The startup raised $75 million in a series C funding round.
Incorporating aquatic therapy can enhance patient outcomes and shorten recovery times for health care professionals. In the Chicago suburbs, the demand for such programs is rising.
Thirty Madison, which operates three brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led the round, and Johnson & Johnson participated as an investor.
The company offers personalized 3-D printed clear aligners - essentially a form of transparent plastic braces - in a direct to consumer model that it touts as cheaper and more convenient than traditional options.
When San Francisco-based startup Honor was launched in 2015, the need for innovation in the home care industry was clear – and it has only grown starker since. The country’s demographic data shows the issue. By 2035, there will be 78 million people 65 and older in the country and by 2050 it’s estimated that […]
The industry's main lobbying group, PhRMA, updated its direct-to-consumer ad guidelines to include pricing information, but HHS secretary says voluntary action is insufficient.
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one.
ECRI Institute has unveiled a list of 10 emerging innovations healthcare leaders should watch this year. A neonatal MRI system, direct-to-consumer genetic testing and VR for pediatric patients are among the topics that made the cut.
Patients already purchase all varieties of heartburn medicines over-the-counter, that years ago were out of reach. Should we permit patients to buy antibiotics, blood pressure medicines, statins for elevated cholesterol and antidepressants? Why not?
Direct-to-consumer medical testing has a rocky past, but healthcare is changing, deductibles are going up, and the patient is becoming more and more empowered. Quest Diagnostics thinks it's now worth a shot.
The launch is the first in a planned series of personal health programs aimed at empowering older, at-risk patients to get healthy and prevent chronic diseases.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The report lists obvious choices like Quest Diagnostics, LabCorp and 23andMe - and deigns to include even Theranos, despite its recent spate of bad PR.